Ownmor

THE CHLOROPHYLLIN

Beyond the trend.Back to the molecule.

Chlorophyll water became a trend. Trends fade. The molecule underneath (chlorophyllin) has been studied in laboratories, clinics and human trials for over eighty years. This page is a comprehensive evidence dossier — what we know, what we don't, and what we're watching next.

01

Molecule-First

Understand the molecule before building the product.

02

Evidence-Led

Let research and data guide every formulation.

03

Purposeful

Every ingredient earns its place for a reason.

THE IDENTITY CARD
Compound

Chlorophyllin — A natural green pigment derived from plants

Origin

Water-soluble derivative of natural chlorophyll

Structure

Chlorophyll porphyrin ring; magnesium replaced with copper

Regulatory record

Permitted by the US FDA as an OTC internal deodorant; listed food colourant exempt from certification; FSSAI-compliant nutraceutical in India

Ownmor standard

95-100% purity — independent third-party assay · lab tested · every batch

THE TIMELINE

Eight Decades of Scientific Evidence

From clinical wound preparations in the 1940s to landmark PNAS human trials and current Phase 3 research.

1940s–50s
—  The clinic
CLINICAL APPLICATION

Chlorophyllin enters medicine: wound-healing preparations and internal deodorization for colostomy and ileostomy patients. Chlorophyllin-based wound ointments remain available by prescription in the US today.

2001
—  The interceptor
PNAS LANDMARK TRIAL

A randomized, double-blind, placebo-controlled trial in Qidong, China: 180 adults, 300 mg chlorophyllin daily with meals, four months. Result: a 55% reduction in aflatoxin–DNA adducts — a biomarker of carcinogen damage — versus placebo. Published in PNAS. Johns Hopkins researchers name the mechanism: an "interceptor molecule" that binds dietary carcinogens in the gut.

55% Reduction in DNA Damage
2009
—  The confirmation
PHARMACOKINETIC STUDY

Human crossover pharmacokinetic research confirms chlorophyllin taken with food impedes aflatoxin absorption and reduces systemic exposure.

2025
—  Ownmor Biophyll™ launch
THE FORMULATION

While conventional wellness products rely on crude plant colorants and unstandardized green blends, Ownmor pioneers Biophyll™. Developed through extensive extraction trials and strategic harvesting protocols, it delivers pharmaceutical-grade, 95-100% pure Chlorophyllin — a bioactive green pigment engineered for maximum cellular bioavailability and gut interception.

95-100% Assay Purity · Proprietary Extraction Standard
2026
—  The frontier
PHASE 3 TATA MEMORIAL TRIAL

A Phase 3 randomized trial (NCT07164534) at Tata Memorial Hospital is evaluating oral chlorophyllin, an NRF2-pathway activator, against late radiotherapy toxicity in cervical cancer.

NCT07164534 · Phase 3 Investigation
2027
—  Next-generation Biophyll™
THE NEXT GENERATION

Ownmor is launching Next-Generation Biophyll™ — advancing molecular bioavailability, refined delivery systems, and next-tier cellular vitality formulations.

Next-Generation Biophyll™ Launch

Independent, investigator-initiated research — not sponsored by Ownmor. We cite it because the world should know this molecule is being taken seriously.

MECHANISMS, GRADED HONESTLY

What the evidence supports — and how strongly

Human evidence

Interceptor activity

Chlorophyllin forms molecular complexes with certain dietary mutagens (aflatoxins, heterocyclic amines) in the digestive tract, reducing their absorption. Demonstrated in randomized human trials.

Evidence TierHuman Clinical Trials
Established medical use

Internal deodorization

Decades of clinical use; permitted by the US FDA as an OTC internal deodorant at up to 300 mg/day. Documented by the Linus Pauling Institute, Oregon State University.

Evidence TierClinical & Regulatory Use
Preclinical & emerging

Antioxidant and antimutagenic activity

Demonstrated in laboratory studies, including protection of cell membranes against oxidative damage (Kamat et al., Biochimica et Biophysica Acta). Cellular defence

Evidence TierLaboratory & In Vitro

Evidence Library

Real Citations · Verify Every Claim

WHAT WE DON'T CLAIM

The Honest Ledger

Science advances on clarity, not hyperbole. Here is exactly where our molecule begins — and where our claims end.

Laboratory analytical verification
Evidence Standard
The Boundary

Biophyll™ is a dietary supplement. We do not make any medical claims. We track early-stage research on chlorophyllin, fund our own quality checks, and always publish the truth about what works and what is still unproven.

Swipe right for standard ➔
The Standard

One more reason standardization matters: crude, unstandardized chlorophyll products can contain photosensitizing breakdown compounds. Biophyll is defined by what it is — 95-100% pure chlorophyllin — and by what it is not.

✓ 95-100% Pure Assay Verified